More Prescient Therapeutics Limited news
Prescient Therapeutics LimitedASX: PTX

FDA IND Re-Activation Request for Phase Ib/II Trial

Feb 10, 2016 at 8:19 PM EST · Issued by Prescient Therapeutics Limited

Filed with ASX · Feb 10, 2016 at 8:19 PM EST · 2 pages · English

On 6ix: 6ix.com/news/fda-ind-re-activation-request-for-phase-ibii-trial

Prescient Therapeutics Limited on 6ix

Follow Prescient Therapeutics into a list and get an email when it puts out news.

Follow Prescient Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer